Genetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients

Paola Griseri, Ornella Garrone, Alessandra Lo Sardo, Martino Monteverde, Marta Rusmini, Federica Tonissi, M. Merlano, Paolo Bruzzi, C. Lo Nigro, Isabella Ceccherini

Research output: Contribution to journalArticlepeer-review

Abstract

Germline and somatic mutations play a crucial role in breast cancer (BC), driving the initiation, progression, response to therapy and outcome of the disease. Hormonal therapy is limited to patients with tumors expressing steroid hormone receptors, such as estrogen receptor (ER), nevertheless resistance often limits its success. The RET gene is known to be involved in neurocristopathies such as Hirschsprung disease and Multiple Endocrine Neoplasia type 2, in the presence of loss-of-function and gain-of-function mutations, respectively. More recently, RET over-expression has emerged as a new player in ER-positive (ER+) BC, and as a potential target to enhance sensitivity and avoid resistance to tamoxifen therapy. Therefore, targeting the RET pathway may lead to new therapies in ER+ BC. To this end, we have investigated the molecular mechanisms which underlie RET overexpression and its possible modulation in two BC cell lines, MCF7 and T47D, showing different RET expression levels. Moreover, we have carried out a pilot association study in 93 ER+ BC patients. Consistent with the adverse role of RET over-expression in BC, increased overall survival was observed in carriers of the variant allele of SNP rs2435357, a RET polymorphism already known to be associated with reduced RET expression.

Original languageEnglish
Pages (from-to)26465-26479
Number of pages15
JournalOncotarget
Volume7
Issue number18
DOIs
Publication statusPublished - May 1 2016

Keywords

  • Breast cancer
  • Gene expression
  • Resistance to hormonal therapy
  • RET gene
  • Single nucleotide polymorphism

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Genetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients'. Together they form a unique fingerprint.

Cite this